Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Vertex Trial on Hold

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 02, 2022 7:38pm

127 Views

Post# 34649559

RE:RE:RE:RE:RE:RE:Vertex Trial on Hold

Mice have been cured of diabetes over and over for years. What works in mice doesn't always work in humans so I'd take that statement with more than a grain of salt. Maybe a box.

MoneyMouth wrote:
As per thr AGM, the conformal coating technology IS WORKING preclinically so far. As in, white blood cells can't get in, and insulin can get out

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario